Skip to main content
Premium Trial:

Request an Annual Quote

Ain't No River Wide Enough

Premium

April showers and May flowers notwithstanding, the Sanger Centre learned that more prosaic November showers bring … well, floods. That Sanger was built on a flood plain didn’t help. “The river that goes just past us had burst its banks,” says Tim Hubbard, the center’s director of genomic analysis. “It flooded the whole area. … We had the fire brigade pumping water out, but this didn’t stop it from getting into the ground floor of the building.”

Sangerites rose to the challenge. Eager to protect their ground floor treasures — a store of ABI Prism 3700s and their connected computers, sample freezers, and refrigerators — employees carted the heavy equipment to the elevator and up to dry quarters on the second floor. Before the computers could be moved, though, “the water really came in and the lifts were turned off,” Hubbard recalls. Not to be outdone, the Sanger employees formed a human chain and passed the PCs and terminals hand over hand, stair by stair to join the 3700s upstairs.

The flooding prompted concerns about falling behind in the center’s breakneck pace to sequence portions of the human and mouse genome, but the result was just a two-day downturn in production. “I think we had a record month,” Hubbard laughs.

—Marian Moser Jones

 

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.